Borderline Fecal Calprotectin: Repeat Test and Next Steps

Categories
Articles
Gut Health Lab Interpretation 2026 Update Patient-Friendly

A mildly raised stool calprotectin result often settles after infection, anti-inflammatory medicines, or time—but the number, symptoms, and trend determine the next step.

📖 ~11 minutes 📅
📝 Published: 🩺 Medically Reviewed: ✅ Evidence-Based
⚡ Quick Summary v1.0 —
  1. Borderline range: Many adult laboratories call 50–120 or 50–150 µg/g borderline, while others use 100–250 µg/g as an intermediate band.
  2. Repeat timing: Repeat fecal calprotectin about 2–6 weeks after a short-lived diarrhoeal illness has resolved and after discussing NSAID use with a clinician.
  3. Do not stop medicines alone: Ibuprofen, naproxen, aspirin and sometimes proton-pump inhibitors can raise calprotectin; prescribed treatment needs clinician-led review.
  4. Infection clue: Acute bacterial gastroenteritis can produce values above 250 µg/g, so one high result during diarrhoea does not diagnose inflammatory bowel disease.
  5. Referral threshold: A persistently raised result above 250 µg/g, or a rising result with red-flag symptoms, usually merits gastroenterology assessment.
  6. Urgent symptoms: Black stool, substantial rectal bleeding, fever with worsening pain, dehydration, unintentional weight loss, or anaemia need prompt medical assessment.
  7. Context matters: Calprotectin measures neutrophil activity in the gut; it cannot by itself distinguish Crohn’s disease, ulcerative colitis, infection, diverticulitis, cancer, or drug-related irritation.
  8. Practical record: Save the exact assay, unit, bowel symptoms, medicines, recent travel, antibiotics and test date before repeating.

What should you do first after a borderline result?

Borderline fecal calprotectin what to do: do not assume inflammatory bowel disease from one mildly raised stool result. Check the laboratory’s reference interval, record recent diarrhoea and medicines, and arrange a repeat test in roughly 2–6 weeks if you are clinically well and have no alarm symptoms.

Borderline fecal calprotectin what to do shown through a stool assay cartridge and intestinal model
Figure 1: A stool inflammation assay is interpreted alongside symptoms and recent exposures.

As of August 28, 2026, a result near the cutoff is best treated as a signal to review context, not a diagnosis. In my clinic, a value of 82 µg/g in someone recovering from a 48-hour stomach bug leads to a very different plan from 82 µg/g with six weeks of nocturnal diarrhoea and falling haemoglobin.

Fecal calprotectin reflects neutrophils entering the intestinal lumen, so it is sensitive to gut inflammation but not specific to its cause. Kantesti is an AI blood test interpretation platform that helps place related results—such as CRP, full blood count, ferritin and albumin—beside a stool result, while making clear that a stool marker cannot diagnose IBD alone.

Write down the date, result, unit, bowel frequency, Bristol stool type, recent travel, antibiotic exposure and every regular or occasional medicine. The Bristol stool chart is surprisingly useful here because watery stool, urgency and overnight waking change the pre-test probability far more than a 10 µg/g difference near a cutoff.

Which fecal calprotectin values are truly borderline?

Adult fecal calprotectin below 50 µg/g is commonly considered normal, but borderline and referral thresholds vary by assay and local pathway. A number of UK pathways use 100–250 µg/g as an intermediate band and values above 250 µg/g as a stronger indication of active intestinal inflammation.

Borderline fecal calprotectin what to do with assay wells representing low intermediate and high ranges
Figure 2: Assay-specific cutoffs explain why identical symptoms can receive different laboratory flags.

A 60 µg/g result is only mildly above a 50 µg/g cutoff; it is not equivalent to 220 µg/g. The British Society of Gastroenterology notes that a threshold of 250 µg/g is often used to indicate active inflammation in known IBD, although the right cutoff depends on whether the question is diagnosis, relapse monitoring or referral (Lamb et al., 2019).

Different tests use different antibodies, extraction devices and calibration methods, so comparison should ideally use the same laboratory. Kantesti AI reads the printed laboratory range first and does not relabel a result as severe merely because another laboratory would flag it differently; understanding an out-of-range flag prevents a lot of needless panic.

A value under 100 µg/g in an adult without red flags makes active IBD less likely, but it does not rule out coeliac disease, bile-acid diarrhoea, microscopic colitis, infection or colorectal disease. Conversely, a value above 250 µg/g deserves clinical attention but still requires cause-finding rather than an automatic Crohn’s label.

Common adult normal band <50 µg/g Active neutrophil-driven intestinal inflammation is less likely.
Low borderline band 50–100 µg/g Review infection, medicines and symptoms; repeat is often reasonable.
Intermediate band 100–250 µg/g Repeat or assess sooner depending on symptoms, age and risk factors.
Clearly elevated >250 µg/g Persistent elevation generally warrants clinician assessment and often GI referral.

When should a fecal calprotectin repeat test be done?

Most clinically stable adults with mildly elevated fecal calprotectin can repeat the test after 2–6 weeks, once acute diarrhoea has settled and reversible confounders have been addressed. Repeating it the next day usually adds noise rather than clarity.

Borderline fecal calprotectin what to do illustrated as timed specimen collection over several weeks
Figure 3: Spacing repeat samples helps distinguish temporary irritation from a persistent pattern.

For a result of 50–100 µg/g with improving symptoms, I commonly use a 4-week repeat; for 100–250 µg/g, 2–4 weeks is reasonable if symptoms persist but there are no urgent features. A repeat should not delay review in a person with visible blood, weight loss, iron-deficiency anaemia or severe pain.

Do not try to manipulate the result with fasting, restrictive diets or laxatives. Keep your usual diet for several days, avoid collecting from toilet water or urine, and follow the kit’s storage instructions; sample handling and biological variation can create changes that look larger than they are. Our guide to genuine changes between laboratory visits explains why trends need a clinical timeline.

Thomas Klein, MD, has seen patients repeat a test after only 72 hours and become alarmed by an inconsequential swing from 96 to 118 µg/g. What changes management is a sustained rise, especially a doubling toward or beyond 250 µg/g, not minor movement around a cutoff.

Can an infection cause a fecal calprotectin false positive?

Yes—gastrointestinal infections are a common cause of a fecal calprotectin false positive for IBD. Campylobacter, Salmonella, Shigella, C. difficile and some parasitic infections can raise calprotectin substantially during active diarrhoea.

Borderline fecal calprotectin what to do with stool sample processing and travel health records
Figure 4: Recent infection and travel can explain a temporary inflammatory stool result.

Calprotectin is not falsely detecting inflammation during infectious diarrhoea; the inflammation is real, but its cause may be transient rather than chronic IBD. Waugh et al. found that fecal calprotectin is useful for separating inflammatory from non-inflammatory bowel conditions, yet it cannot reliably identify the specific inflammatory diagnosis (Waugh et al., 2013).

Ask about symptoms in the prior 4 weeks: fever, vomiting, sick contacts, travel, untreated water, antibiotics, hospital admission and new food exposures. Stool PCR or culture is particularly useful when diarrhoea is ongoing, and our explanation of stool culture results outlines why a detected organism still needs clinical interpretation.

A calprotectin test taken during active infectious diarrhoea should usually be repeated after recovery rather than used to diagnose IBD. If diarrhoea lasts more than 7 days, is bloody, follows antibiotics, or is accompanied by fever above 38.0°C, contact a clinician rather than waiting on a routine repeat.

Which medicines can raise calprotectin without IBD?

NSAIDs are the clearest medication confounder for a mildly elevated fecal calprotectin result. Ibuprofen, naproxen, diclofenac and aspirin can irritate the small bowel and increase intestinal neutrophil activity, sometimes even when there is little pain.

Borderline fecal calprotectin what to do beside NSAID medicine blister packs and stool assay equipment
Figure 5: Medication review is part of interpreting a mild stool inflammation signal.

A practical approach is to ask the prescriber whether non-essential NSAIDs can be avoided for about 2 weeks before repeating calprotectin; do not stop aspirin prescribed after a heart attack, stroke or stent without direct medical advice. NSAID enteropathy is easy to miss because it may cause occult irritation without classic indigestion.

Proton-pump inhibitors such as omeprazole are associated with modest elevations in some observational studies, but the evidence is honestly mixed and stopping them can be unsafe in people with ulcer disease or severe reflux. Also review metformin, antibiotics, immune therapies and laxatives; a complete medication list is more useful than guessing from one drug.

Kantesti is an AI-powered blood test analysis tool that can organise medicine-linked laboratory context, including low ferritin or CRP elevation, but a clinician must decide whether a medicine change is appropriate. If long-term acid suppression is part of the story, our article on monitoring during PPI use covers the blood markers clinicians commonly follow.

Could sample collection or natural variation explain a mild rise?

Collection errors rarely create a large calprotectin result, but uneven stool sampling, assay differences and day-to-day biology can move a borderline value across the cutoff. This is why the same kit, laboratory and collection method matter for a fecal calprotectin repeat test.

Borderline fecal calprotectin what to do with clean home sample kit and sealed laboratory container
Figure 6: Consistent home collection reduces avoidable variation in repeat stool testing.

Collect from a clean, dry receptacle rather than directly from toilet water, and avoid mixing the sample with urine or cleaning products. Take small portions from more than one area if the kit instructs this, because mucus and softer regions may contain different concentrations of inflammatory material.

Avoid interpreting a borderline result from a sample collected immediately after colonoscopy preparation, an enema, or a major diarrhoeal episode as a steady baseline. For people with variable bowel habits, I suggest noting the stool form and whether there was mucus or visible blood on the collection day; our guide to mucus in stool explains when that observation matters.

A change from 55 to 72 µg/g may be analytically unremarkable, whereas a rise from 75 to 380 µg/g is much harder to dismiss. Keep the report rather than relying on a portal flag—assay name and laboratory range are clinically meaningful details.

Which symptoms warrant GI review instead of waiting to repeat?

Rectal bleeding, unintentional weight loss, nocturnal diarrhoea, persistent fever, iron-deficiency anaemia and a palpable abdominal mass warrant medical review regardless of a borderline calprotectin value. The result should never overrule concerning symptoms.

Borderline fecal calprotectin what to do with clinician reviewing symptom diary and laboratory results
Figure 7: Alarm symptoms outweigh a borderline stool result when deciding referral urgency.

Seek urgent same-day assessment for black tarry stool, heavy rectal bleeding, fainting, severe or escalating abdominal pain, inability to keep fluids down, confusion, or signs of significant dehydration. These are triage symptoms, not calprotectin thresholds; a low or borderline number does not make them safe to ignore.

A GP review within days is sensible for weight loss of more than 5% of body weight in 6–12 months, diarrhoea that wakes you from sleep, fever, new bowel change after age 50, or a close family history of colorectal cancer or IBD. A positive FIT or FOBT result follows a different diagnostic pathway and should not be explained away by calprotectin.

The reason anaemia changes the picture is that chronic intestinal inflammation, microscopic blood loss and malabsorption can coexist. A full blood count, ferritin and CRP may be more informative together than any isolated stool value.

What will a GP usually check after a mild elevation?

A GP commonly pairs a mildly elevated fecal calprotectin result with a symptom review, abdominal examination, full blood count, CRP or ESR, ferritin, coeliac serology and stool infection testing when indicated. The objective is to identify who needs fast referral and who can safely retest.

Borderline fecal calprotectin what to do with primary care clinician reviewing blood and stool reports
Figure 8: Primary care assessment combines stool inflammation with anaemia and systemic inflammation clues.

A full blood count can identify anaemia, raised platelets or an elevated white count, while CRP reflects systemic rather than bowel-specific inflammation. A normal CRP does not exclude Crohn’s disease, particularly isolated ileal disease, but normal CRP, albumin and haemoglobin make severe active inflammation less likely.

Coeliac screening should include tissue transglutaminase IgA and total IgA while the person is eating gluten. If total IgA is low, standard IgA-based coeliac tests may be falsely reassuring; see our practical guide to low IgA and coeliac pitfalls for the usual next step.

Thomas Klein, MD, advises bringing one page of facts to the appointment: symptom onset, stool frequency, medications, family history, prior colonoscopy, travel and the actual result. It makes the consultation sharper, particularly when symptoms have been intermittent for months.

Does borderline calprotectin mean IBS or inflammatory bowel disease?

Borderline fecal calprotectin does not diagnose either IBS or IBD. IBS usually has a normal result, whereas persistent elevation increases suspicion of IBD, but infection, diverticular disease, coeliac disease, colorectal neoplasia and NSAID injury remain possible explanations.

Borderline fecal calprotectin what to do using comparative intestinal tissue response models
Figure 9: Persistent inflammation needs diagnosis; calprotectin alone cannot name the condition.

IBS can produce cramping, bloating and altered stool frequency without neutrophil-driven intestinal inflammation, so calprotectin below 50 µg/g supports—but does not prove—an IBS-type explanation. In adults with a first borderline result, the clinical question is often whether symptoms and trend justify colonoscopy, not whether the patient must choose an IBS or IBD label today.

Crohn’s disease may involve the small bowel and ulcerative colitis typically affects the colon, yet both can show raised calprotectin. Microscopic colitis can occasionally have normal or only modestly elevated calprotectin, which is one reason watery diarrhoea in adults over 50 can still merit investigation despite an unimpressive number.

Kantesti AI interprets related blood markers by checking for patterns such as low albumin, iron deficiency and inflammatory thrombocytosis alongside the stool result. For comparison, fecal lactoferrin is another neutrophil-associated stool marker, though it faces many of the same specificity limits.

How do age, pregnancy and known IBD alter the pathway?

Children, older adults, pregnant people and patients with established IBD need individualized fecal calprotectin interpretation. Young children can have higher baseline values, while new bowel symptoms after age 50 should not be managed by repeat testing alone.

Borderline fecal calprotectin what to do with paediatric and adult laboratory sample pathways
Figure 10: Age and clinical setting change the meaning of the same calprotectin value.

Infants and toddlers often have calprotectin values well above adult cutoffs, so adult ranges should not be applied to a child without paediatric guidance. A child with poor growth, blood in stool, persistent diarrhoea or significant abdominal pain needs paediatric assessment rather than repeated home testing; low stool pH in children may answer a different question about carbohydrate malabsorption.

Pregnancy itself is not a reason to dismiss new persistent diarrhoea, blood in stool or weight loss. Calprotectin can assist evaluation, but obstetric, infectious and GI teams should interpret it with the full pregnancy history and medication list.

For established IBD, a result above 250 µg/g may suggest mucosal inflammation even when symptoms are mild, but treatment should not be altered solely from a home result. BSG guidance supports using calprotectin as one component of relapse assessment, alongside symptoms, blood markers and sometimes endoscopy (Lamb et al., 2019).

What should you avoid doing after a mild elevation?

Do not self-start steroids, eliminate multiple foods, stop prescribed medicines, or order repeated daily calprotectin tests after a mildly elevated result. These actions can blur the diagnostic picture and, in some cases, create real harm.

Borderline fecal calprotectin what to do with clinician-guided medication review and sealed home test kit
Figure 12: A planned repeat test is safer than abrupt treatment changes or excessive testing.

Steroids can lower inflammatory markers while masking infection, and unnecessary dietary restriction can worsen weight loss or iron deficiency. If symptoms suggest IBD, diagnosis generally requires clinical assessment and often endoscopic or imaging evidence before long-term treatment begins.

Do not use calprotectin as a bowel cancer screening test. FIT detects human haemoglobin and is used in colorectal cancer pathways; calprotectin measures inflammatory activity, so the tests answer different questions. Our comparison of FIT and colonoscopy explains why a negative stool marker never replaces appropriate age- and risk-based screening.

There is no reliable supplement that safely lowers calprotectin as a target in its own right. Treating the number instead of the cause is a little like silencing a smoke alarm without checking the room.

How can you prepare for a gastroenterology appointment?

Bring a dated symptom and medication timeline, every stool result with its laboratory range, family history, prior imaging or endoscopy reports, and recent blood tests to a GI appointment. This can reduce duplicated testing and helps the specialist judge urgency.

Borderline fecal calprotectin what to do with organised reports and gastroenterology consultation notes
Figure 13: An organised timeline helps gastroenterology distinguish transient illness from chronic disease.

Useful questions include: Could this be infection or NSAID injury? Do I need stool PCR, coeliac serology, FIT, colonoscopy, small-bowel imaging or a repeat calprotectin? Ask what threshold and time interval would trigger escalation in your own case, because local pathways differ.

If colonoscopy is recommended, it is usually because symptoms, age, family history, anaemia or persistent inflammation justify direct assessment of the colon—not because a calprotectin result has diagnosed cancer. A low ferritin without heavy periods can add weight to investigation; our guide to GI clues in low ferritin explains why.

Kantesti AI can prepare a concise laboratory chronology for discussion, but it does not replace specialist assessment. Readers can also review our clinical standards and oversight through medical validation before using any automated interpretation as part of appointment preparation.

A practical decision pathway for mildly raised calprotectin

For a mildly elevated fecal calprotectin result, review red flags first, exclude active infection and medicine effects next, then repeat in 2–6 weeks if clinically appropriate. Persistently raised values, values above 250 µg/g, or concerning symptoms should move the pathway toward GP or gastroenterology review.

Borderline fecal calprotectin what to do shown as a clinician-led repeat testing decision pathway
Figure 14: A symptom-first pathway identifies who can repeat safely and who needs referral.

If the result is 50–100 µg/g and you feel well or are recovering from a clear short-lived illness, document confounders and arrange a planned repeat. If it is 100–250 µg/g, contact your GP to decide whether to repeat promptly, add blood and infection tests, or refer based on the clinical picture.

If the repeat drops below the laboratory cutoff and symptoms resolve, no further calprotectin testing may be needed. If it remains elevated, rises, or is joined by weight loss, night symptoms, blood, fever, anaemia or raised CRP, investigation should progress rather than looping through repeated home kits.

Kantesti’s physician-reviewed approach is designed to explain laboratory context without pretending that an algorithm can examine an abdomen or make an endoscopic diagnosis. The Medical Advisory Board informs our safety standards, and the blood test biomarkers guide can help you understand the companion blood markers a clinician may request.

Frequently Asked Questions

Is 80 µg/g fecal calprotectin high?

A fecal calprotectin result of 80 µg/g is mildly elevated if the laboratory uses an adult cutoff of 50 µg/g, but it is often treated as borderline rather than diagnostic of IBD. Recent diarrhoea, NSAID use and sample timing can explain this range. In a clinically stable adult without alarm symptoms, clinicians commonly repeat the test after about 2–6 weeks. Persistent symptoms or a rising result should prompt GP review sooner.

How long should I wait to repeat fecal calprotectin?

Most adults with a mildly elevated fecal calprotectin result repeat it after 2–6 weeks, once an acute gastrointestinal illness has resolved. A 4-week interval is commonly practical for values around 50–100 µg/g, while 100–250 µg/g may justify earlier clinician contact. The repeat should use the same laboratory where possible. Do not delay assessment if there is rectal bleeding, weight loss, anaemia, fever or severe pain.

Can ibuprofen raise fecal calprotectin?

Ibuprofen and other NSAIDs, including naproxen and diclofenac, can raise fecal calprotectin by causing intestinal irritation. Clinicians may advise avoiding non-essential NSAIDs for roughly 2 weeks before a repeat test, but prescribed aspirin or anti-inflammatory treatment should never be stopped without medical advice. NSAID-related elevations can overlap with the 50–250 µg/g borderline range. A medication timeline is therefore part of a reliable interpretation.

Can a stomach infection cause high fecal calprotectin?

A bacterial or parasitic gastrointestinal infection can raise fecal calprotectin well above 250 µg/g because it causes genuine intestinal neutrophil activity. This does not mean the person has Crohn’s disease or ulcerative colitis. Ongoing diarrhoea, fever, travel exposure, antibiotic use or sick contacts may justify stool PCR or culture. Repeat calprotectin is usually more informative after the infection has resolved.

What calprotectin level needs a colonoscopy?

No single fecal calprotectin value automatically requires colonoscopy because symptoms, age, anaemia, family history and test trends determine the decision. Persistent values above 250 µg/g commonly support gastroenterology referral, especially with diarrhoea or raised CRP. A person over 50 with a new bowel habit change or iron-deficiency anaemia may need investigation even if calprotectin is below 100 µg/g. Conversely, a temporary result of 120 µg/g after gastroenteritis may settle on repeat.

Can IBS cause borderline fecal calprotectin?

IBS usually has fecal calprotectin below 50 µg/g, although minor borderline elevations can occur and do not automatically exclude IBS. A persistent value above 100–150 µg/g should prompt clinicians to consider inflammation, infection, medications and alternative diagnoses rather than assigning IBS without review. IBS symptoms can coexist with IBD, so symptom pattern and trend are both relevant. Night-time diarrhoea, bleeding, weight loss and anaemia are not typical IBS features and need assessment.

Get AI-Powered Blood Test Analysis Today

Join over 2 million users worldwide who trust Kantesti for instant, accurate lab test analysis. Upload your blood test results and receive comprehensive interpretation of 15,000+ biomarkers in seconds.

📚 Referenced Research Publications

1

Klein, T., Mitchell, S., & Weber, H. (2026). Klein, T. et al. (2026). Multilingual AI Assisted Clinical Decision Support for Early Hantavirus Triage: Design, Engineering Validation, and Real-World Deployment Across 50,000 Interpreted Blood Test Reports. Figshare. https://doi.org/10.6084/m9.figshare.32230290. ResearchGate: https://www.researchgate.net. Academia.edu: https://www.academia.edu.. Kantesti AI Medical Research.

2

Klein, T., Mitchell, S., & Weber, H. (2026). Klein, T. et al. (2026). A Pre-Registered, Rubric-Based Automated Technical Benchmark of the Kantesti Blood-Test Interpretation Engine on 100,000 Synthetic Test Cases. Figshare. https://doi.org/10.6084/m9.figshare.32095435. ResearchGate: https://www.researchgate.net. Academia.edu: https://www.academia.edu.. Kantesti AI Medical Research.

📖 External Medical References

3

Lamb CA et al. (2019). British Society of Gastroenterology consensus guidelines on the management of inflammatory bowel disease in adults. Gut.

4

Waugh N et al. (2013). Faecal calprotectin testing for differentiating amongst inflammatory and non-inflammatory bowel diseases: systematic review and economic evaluation. Health Technology Assessment.

5

Walsham NE and Sherwood RA (2016). Fecal calprotectin in inflammatory bowel disease. Clinical and Experimental Gastroenterology.

2M+Tests Analyzed
127+Countries
75+Languages

⚕️ Medical Disclaimer

E-E-A-T Trust Signals

Experience

Physician-led clinical review of lab interpretation workflows.

📋

Expertise

Laboratory medicine focus on how biomarkers behave in clinical context.

👤

Authoritativeness

Written by Dr. Thomas Klein with review by Dr. Sarah Mitchell and Prof. Dr. Hans Weber.

🛡️

Trustworthiness

Evidence-based interpretation with clear follow-up pathways to reduce alarm.

🏢 Kantesti LTD Registered in England & Wales · Company No. 17090423 London, United Kingdom · kantesti.net
blank
By Prof. Dr. Thomas Klein

Dr. Thomas Klein is a board-certified clinical hematologist serving as Chief Medical Officer at Kantesti AI. With over 15 years of experience in laboratory medicine and a strong interest in AI-supported interpretation of blood test results, he works to connect new technology with everyday clinical practice. His areas of interest include biomarker analysis, clinical decision support research and population-specific reference range optimization. As CMO, he contributes clinical input to the platform's internal benchmarking and provides clinical oversight for the medical quality of Kantesti's educational reports.

Leave a Reply

Your email address will not be published. Required fields are marked *